ArticleRSC advances2025

Hybrid nucleobase-heterocycle-2-oxindole scaffolds as innovative cell cycle modulators with potential anticancer activity.

Gehan Ahmed Abdel-Hafez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.